ID   HYAS2_HUMAN             Reviewed;         552 AA.
AC   Q92819; Q32MM3;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   10-MAY-2017, entry version 135.
DE   RecName: Full=Hyaluronan synthase 2;
DE            EC=2.4.1.212;
DE   AltName: Full=Hyaluronate synthase 2;
DE   AltName: Full=Hyaluronic acid synthase 2;
DE            Short=HA synthase 2;
GN   Name=HAS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8798477; DOI=10.1074/jbc.271.38.22945;
RA   Watanabe K., Yamaguchi Y.;
RT   "Molecular identification of a putative human hyaluronan synthase.";
RL   J. Biol. Chem. 271:22945-22948(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   CHROMOSOMAL REARRANGEMENT WITH PLAG1.
RX   PubMed=15642402; DOI=10.1016/j.cancergencyto.2004.04.017;
RA   Morerio C., Rapella A., Rosanda C., Tassano E., Gambini C.,
RA   Romagnoli G., Panarello C.;
RT   "PLAG1-HAS2 fusion in lipoblastoma with masked 8q intrachromosomal
RT   rearrangement.";
RL   Cancer Genet. Cytogenet. 156:183-184(2005).
CC   -!- FUNCTION: Catalyzes the addition of GlcNAc or GlcUA
CC       monosaccharides to the nascent hyaluronan polymer. Therefore, it
CC       is essential to hyaluronan synthesis a major component of most
CC       extracellular matrices that has a structural role in tissues
CC       architectures and regulates cell adhesion, migration and
CC       differentiation. This is one of the isozymes catalyzing that
CC       reaction and it is particularly responsible for the synthesis of
CC       high molecular mass hyaluronan. Required for the transition of
CC       endocardial cushion cells into mesenchymal cells, a process
CC       crucial for heart development. May also play a role in
CC       vasculogenesis. High molecular mass hyaluronan also play a role in
CC       early contact inhibition a process which stops cell growth when
CC       cells come into contact with each other or the extracellular
CC       matrix (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-N-acetyl-D-glucosamine + beta-D-
CC       glucuronosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->4)-(nascent
CC       hyaluronan) = UDP + N-acetyl-beta-D-glucosaminyl-(1->4)-beta-D-
CC       glucuronosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->4)-(nascent
CC       hyaluronan).
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-glucuronate + N-acetyl-beta-D-
CC       glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->3)-(nascent
CC       hyaluronan) = UDP + beta-D-glucuronosyl-(1->3)-N-acetyl-beta-D-
CC       glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->3)-(nascent
CC       hyaluronan).
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- PATHWAY: Glycan biosynthesis; hyaluronan biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in fibroblasts.
CC   -!- DISEASE: Note=A chromosomal aberration involving HAS2 may be a
CC       cause of lipoblastomas, which are benign tumors resulting from
CC       transformation of adipocytes, usually diagnosed in children.
CC       8q12.1 to 8q24.1 intrachromosomal rearrangement with PLAG1.
CC       {ECO:0000269|PubMed:15642402}.
CC   -!- SIMILARITY: Belongs to the NodC/HAS family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/HAS2ID412ch8q24.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U54804; AAC50692.1; -; mRNA.
DR   EMBL; BC069353; AAH69353.1; -; mRNA.
DR   EMBL; BC109071; AAI09072.1; -; mRNA.
DR   EMBL; BC109072; AAI09073.1; -; mRNA.
DR   CCDS; CCDS6335.1; -.
DR   RefSeq; NP_005319.1; NM_005328.2.
DR   UniGene; Hs.159226; -.
DR   UniGene; Hs.668686; -.
DR   ProteinModelPortal; Q92819; -.
DR   BioGrid; 109287; 2.
DR   STRING; 9606.ENSP00000306991; -.
DR   CAZy; GT2; Glycosyltransferase Family 2.
DR   iPTMnet; Q92819; -.
DR   PhosphoSitePlus; Q92819; -.
DR   BioMuta; HAS2; -.
DR   DMDM; 7387737; -.
DR   PaxDb; Q92819; -.
DR   PeptideAtlas; Q92819; -.
DR   PRIDE; Q92819; -.
DR   Ensembl; ENST00000303924; ENSP00000306991; ENSG00000170961.
DR   GeneID; 3037; -.
DR   KEGG; hsa:3037; -.
DR   UCSC; uc003yph.3; human.
DR   CTD; 3037; -.
DR   DisGeNET; 3037; -.
DR   GeneCards; HAS2; -.
DR   HGNC; HGNC:4819; HAS2.
DR   HPA; HPA052060; -.
DR   MIM; 601636; gene.
DR   neXtProt; NX_Q92819; -.
DR   OpenTargets; ENSG00000170961; -.
DR   PharmGKB; PA29195; -.
DR   eggNOG; KOG2571; Eukaryota.
DR   eggNOG; COG1215; LUCA.
DR   GeneTree; ENSGT00390000010337; -.
DR   HOGENOM; HOG000112847; -.
DR   HOVERGEN; HBG000189; -.
DR   InParanoid; Q92819; -.
DR   KO; K00752; -.
DR   OMA; TAYIMGY; -.
DR   OrthoDB; EOG091G04P3; -.
DR   PhylomeDB; Q92819; -.
DR   TreeFam; TF332506; -.
DR   BRENDA; 2.4.1.212; 2681.
DR   Reactome; R-HSA-2142850; Hyaluronan biosynthesis and export.
DR   UniPathway; UPA00341; -.
DR   ChiTaRS; HAS2; human.
DR   GeneWiki; HAS2; -.
DR   GenomeRNAi; 3037; -.
DR   PRO; PR:Q92819; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000170961; -.
DR   CleanEx; HS_HAS2; -.
DR   Genevisible; Q92819; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0050501; F:hyaluronan synthase activity; IMP:BHF-UCL.
DR   GO; GO:0036302; P:atrioventricular canal development; ISS:UniProtKB.
DR   GO; GO:0060349; P:bone morphogenesis; IEA:Ensembl.
DR   GO; GO:0071498; P:cellular response to fluid shear stress; IEP:BHF-UCL.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:BHF-UCL.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IDA:UniProtKB.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:BHF-UCL.
DR   GO; GO:0090500; P:endocardial cushion to mesenchymal transition; ISS:UniProtKB.
DR   GO; GO:0044849; P:estrous cycle; IEA:Ensembl.
DR   GO; GO:0085029; P:extracellular matrix assembly; ISS:UniProtKB.
DR   GO; GO:0045226; P:extracellular polysaccharide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0030213; P:hyaluronan biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0001822; P:kidney development; ISS:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL.
DR   GO; GO:1900127; P:positive regulation of hyaluronan biosynthetic process; IEA:Ensembl.
DR   GO; GO:0051549; P:positive regulation of keratinocyte migration; IEA:Ensembl.
DR   GO; GO:0010838; P:positive regulation of keratinocyte proliferation; IEA:Ensembl.
DR   GO; GO:1900625; P:positive regulation of monocyte aggregation; IMP:BHF-UCL.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; IEA:Ensembl.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IEA:Ensembl.
DR   GO; GO:0035810; P:positive regulation of urine volume; ISS:UniProtKB.
DR   GO; GO:0070295; P:renal water absorption; ISS:UniProtKB.
DR   GO; GO:0001570; P:vasculogenesis; ISS:UniProtKB.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR028371; HAS2.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR22913:SF17; PTHR22913:SF17; 1.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   SUPFAM; SSF53448; SSF53448; 2.
PE   2: Evidence at transcript level;
KW   Chromosomal rearrangement; Complete proteome; Glycosyltransferase;
KW   Membrane; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    552       Hyaluronan synthase 2.
FT                                /FTId=PRO_0000197173.
FT   TOPO_DOM      1     11       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     12     32       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     33     45       Extracellular. {ECO:0000255}.
FT   TRANSMEM     46     66       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM     67    374       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    375    395       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    396    402       Extracellular. {ECO:0000255}.
FT   TRANSMEM    403    423       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    424    429       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    430    450       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    451    475       Extracellular. {ECO:0000255}.
FT   TRANSMEM    476    496       Helical; Name=6. {ECO:0000255}.
FT   TOPO_DOM    497    510       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    511    531       Helical; Name=7. {ECO:0000255}.
FT   TOPO_DOM    532    552       Extracellular. {ECO:0000255}.
SQ   SEQUENCE   552 AA;  63566 MW;  EEEF58D97B131F9D CRC64;
     MHCERFLCIL RIIGTTLFGV SLLLGITAAY IVGYQFIQTD NYYFSFGLYG AFLASHLIIQ
     SLFAFLEHRK MKKSLETPIK LNKTVALCIA AYQEDPDYLR KCLQSVKRLT YPGIKVVMVI
     DGNSEDDLYM MDIFSEVMGR DKSATYIWKN NFHEKGPGET DESHKESSQH VTQLVLSNKS
     ICIMQKWGGK REVMYTAFRA LGRSVDYVQV CDSDTMLDPA SSVEMVKVLE EDPMVGGVGG
     DVQILNKYDS WISFLSSVRY WMAFNIERAC QSYFGCVQCI SGPLGMYRNS LLHEFVEDWY
     NQEFMGNQCS FGDDRHLTNR VLSLGYATKY TARSKCLTET PIEYLRWLNQ QTRWSKSYFR
     EWLYNAMWFH KHHLWMTYEA IITGFFPFFL IATVIQLFYR GKIWNILLFL LTVQLVGLIK
     SSFASCLRGN IVMVFMSLYS VLYMSSLLPA KMFAIATINK AGWGTSGRKT IVVNFIGLIP
     VSVWFTILLG GVIFTIYKES KRPFSESKQT VLIVGTLLYA CYWVMLLTLY VVLINKCGRR
     KKGQQYDMVL DV
//
